74%
de las cuentas minoristas pierden dinero al operar CFDs con este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierden dinero cuando operan con CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs, y si puedes permitirte asumir el alto riesgo de perder tu dinero.
74%
de las cuentas minoristas pierden dinero al operar CFDs con este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierden dinero cuando operan con CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs, y si puedes permitirte asumir el alto riesgo de perder tu dinero.
Español (Latinoamérica)
Ackermans & van Haaren NV
Abierto
SectorFinanzas
211 0.67
Resumen
Variación precio
24h
Mínimo
208.8
Máximo
211.6
Ingresos | 200M |
|---|---|
Ventas | 2.9B |
P/B Media del Sector | 14.363 20.525 |
BPA | 6.121 |
Rentabilidad por dividendo | 1.88 |
Margen de beneficio | 6.945 |
Empleados | 24,384 |
EBITDA | 516M |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 meses | +17.31% upside |
Rentabilidad por dividendo Media del Sector | 1.88% 4.36% |
|---|---|
Próximas Ganancias | 22 may 2025 |
Capitalización de Mercado | 454M 6.6B |
|---|---|
Apertura anterior | 210.33 |
Cierre anterior | 211 |
Ackermans & van Haaren NV Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Ackermans & van Haaren NV Esperado
Precio Objetivo
By TipRanks
17.31% repunte
Estimación a 12 meses
Media 185 EUR 17.31%
Máximo 185 EUR
Mínimo 185 EUR
De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ackermans & van Haaren NV Dist en los últimos 3 meses.
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Ackermans & van Haaren NV
Ackermans & Van Haaren NV engages in marine engineering and contracting, private banking, real estate and senior care, and energy and resources businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; specialized advisory banking services for entrepreneurs and liberal professionals; and financing and financial leasing of cars, equipment, charging stations, and bicycles. The Real Estate & Senior Care segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions; and develops residential, and retail and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital provides engineering and solutions in production process automation; validation and compliance services; production and sale of compact biogas installations; manufactures and supplies specialty chemicals; provides broadcast and media solutions; online and printed news; logistics for rail and road transport, and intermodal transport, and warehousing services; develops new vaccines, and crop and food protection products; and deals and leases commercial vehicles, and distribution of aftermarket products. This segment also develops medical devices; medicines for the treatment of cancer and genetic diseases; and supplies medical equipment and consumables to hospitals through online. The company was founded in 1876 and is based in Antwerp, Belgium.
